About Avivomed
Avivomed is a private company based in Roseville, Minnesota, incorporated in 2021 in Delaware. It has reported $25,118,334 raised in two offerings on Form D since November 2021. Its chief executive is Paul Mazanec.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 21, 2026 | $5,000,000of $12.0M target | 7 | $714K | Debt, OptionsRule 506(b) | Form D ↗ |
| Nov 3, 2021 | Nov 16, 2021 | $20,118,334of $32.0M target | 6 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $25,118,334 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avivomed's Form D filed Apr 21, 2026.
TP
Theresa Pappas
Director
Ketan Patel
Director
Casper de Clercq
Director
Douglas Reed
Director
Mudit Jain
Co-Founder and director
Also a director at Neochord and an executive officer and director at ShiraTronics and iVEAcare.
Earlier filings also listed Stephen Masson (executive officer and director, last listed Nov 2021).